SPG50 Phase I/II Clinical Protocol
Description
Full clinical protocol for an AAV9 gene therapy IND for SPG50, shared publicly as a model for the rare disease gene therapy community.
Providing Organization
Category
Therapeutic Modality
Jurisdiction
Description
Full clinical protocol for an AAV9 gene therapy IND for SPG50, shared publicly as a model for the rare disease gene therapy community.
Providing Organization
Category
Therapeutic Modality
Jurisdiction
0 Comments